ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 373 filers reported holding ENCOMPASS HEALTH CORP in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $109 | -99.7% | 1,621 | +118.2% | 0.02% | +90.0% |
| Q3 2022 | $34,000 | -19.0% | 743 | 0.0% | 0.01% | -16.7% |
| Q2 2022 | $42,000 | -19.2% | 743 | 0.0% | 0.01% | +9.1% |
| Q1 2022 | $52,000 | +6.1% | 743 | 0.0% | 0.01% | +37.5% |
| Q4 2021 | $49,000 | +1533.3% | 743 | +1480.9% | 0.01% | +700.0% |
| Q3 2021 | $3,000 | 0.0% | 47 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | -94.4% | 47 | -92.9% | 0.00% | -100.0% |
| Q1 2021 | $54,000 | -46.0% | 661 | -45.7% | 0.01% | -44.4% |
| Q4 2020 | $100,000 | +316.7% | 1,217 | +230.7% | 0.01% | +350.0% |
| Q3 2020 | $24,000 | -69.6% | 368 | -71.0% | 0.00% | -71.4% |
| Q2 2020 | $79,000 | -25.5% | 1,271 | -23.8% | 0.01% | -41.7% |
| Q1 2020 | $106,000 | +171.8% | 1,669 | +229.8% | 0.01% | +200.0% |
| Q4 2019 | $39,000 | -81.6% | 506 | -81.4% | 0.00% | -88.9% |
| Q3 2018 | $212,000 | +98.1% | 2,714 | +72.1% | 0.04% | +111.8% |
| Q2 2018 | $107,000 | – | 1,577 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
| Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
| Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
| DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
| Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
| Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
| GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
| CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
| EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
| S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |